Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-20 Option Award | 2024-03-25 4:28 pm | N/A 2034-03-20 | 2seventy bio Inc. | TSVT | Newton Charles W. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-13 8:19 pm | N/A 2034-02-08 | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 440,000 | $0 | 448,729 (Direct) | View |
| 2023-11-16 Disposition | 2023-11-20 8:55 pm | N/A 2031-02-04 | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 4,818,000 | $0 | 4,826,729 (Direct) | View |
| 2023-11-16 Option Award | 2023-11-20 8:55 pm | N/A 2031-02-04 | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 4,818,000 | $0 | 4,826,729 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:56 pm | N/A 2033-06-07 | Coherus BioSciences Inc. | CHRS | Newton Charles W. Director | 38,250 | $0 | 38,250 (Direct) | View |
| 2023-02-24 Option Award | 2023-02-28 6:13 pm | N/A 2033-02-23 | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 700,000 | $0 | 702,941 (Direct) | View |
| 2022-05-04 Option Award | 2022-05-06 6:50 pm | N/A 2032-05-04 | Coherus BioSciences Inc. | CHRS | Newton Charles W. Director | 54,000 | $0 | 54,000 (Direct) | View |
| 2022-03-16 Option Award | 2022-03-18 4:09 pm | N/A 2032-03-15 | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 500,000 | $0 | 500,000 (Direct) | View |
Ownership | 2021-06-16 7:21 pm | N/A 2031-02-04 | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 0 | $0 | 4,318,000 (Direct) | View |